sellModerate
Kevin Joseph Howard sold $914k of SNV
EVP, Chief Wholesale Bank. Off at SYNOVUS FINANCIAL CORP. 15,750 shares at an average of $58.02, traded Nov 27, 2024, filed Dec 2, 2024.
Warning score
49Value
$914k
15,750 shares
Holdings after
46,490
-25% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +24Trade size$914k at market
- +10Share of holdings soldSold 25% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000018349-24-000153, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 27, 2024 | SOpen-market sale Common Stock | -15,750 | $58.02 | $914k | 46,490 | Dec 2, 2024 |
| Nov 27, 2024 | POpen-market purchase Common Stock | +7,500 | $58.00 | $435k | 53,990 | Dec 2, 2024 |
Related signals
Other insiders at SYNOVUS FINANCIAL CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 27Weak | SNVbuy SYNOVUS FINANCIAL CORP | Thomas T Dierdorff EVP, Corp. & Inv. Banking | $92k 1,680 shares | +14% | |
| 29Weak | SNVsell SYNOVUS FINANCIAL CORP | Thomas T Dierdorff EVP, Corp. & Inv. Banking | $92k 1,680 shares | -12% | |
| 35Weak | SNVbuy SYNOVUS FINANCIAL CORP | Kevin Joseph Howard EVP, Chief Wholesale Bank. Off | $435k 7,500 shares | +16% | |
| 27Weak | SNVbuy SYNOVUS FINANCIAL CORP | Thomas T Dierdorff EVP, Corp. & Inv. Banking | $90k 1,841 shares | +14% | |
| 29Weak | SNVsell SYNOVUS FINANCIAL CORP | Thomas T Dierdorff EVP, Corp. & Inv. Banking | $90k 1,841 shares | -12% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.